Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol in Severe Sepsis
NCT02794025Completed
- Sponsor
- Fujian Provincial Hospital
- Start
- Jan 2010
- Primary completion
- Jan 2013
- Modality
- Orthosteric Ligands
01
Overview
Single-blind trial of esmolol in sepsis (2 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Survival Time at 28 days. Started Jan 2010; status: completed.
02
Drugs
esmolol
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT02794025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02794025.